Trials / Completed
CompletedNCT00307996
The Effect of CoQ10 Administration on Hemodialysis Patients
The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- University of Shizuoka · Academic / Other
- Sex
- All
- Age
- 0 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.
Detailed description
Oxidative stress has been recognized as a potential risk factor for such complications as atherosclerosis in hemodialysis patients. This study investigates whether CoQ10 administration is effective for protecting oxidative stress in hemodialysis patients. The subjects were recruited from day-time hemodialysis patients in Iwata City Hospital. 100 mg CoQ10 was administered every HD for 6 months. Several oxidative and antioxidative markers were measured in plasma at pre, 1, 3, 6 months and after washout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Coenzyme Q10 (drug) |
Timeline
- Start date
- 2004-03-01
- Completion
- 2004-12-01
- First posted
- 2006-03-28
- Last updated
- 2006-03-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00307996. Inclusion in this directory is not an endorsement.